When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ADAP - Adaptimmune down 37% premarket on disappointing SPEAR cell data
Adaptimmune Therapeutics plc
Adaptimmune Therapeutics plc (NASDAQ:ADAP) slumps 37% premarket on light volume on the heels of its announcement of initial data from the first two cohorts of its ongoing studies evaluating its MAGE-A10 and MAGE-A4 SPEAR T-cells. The results were presented at ESMO in Munich.
More news on: Adaptimmune Therapeutics plc, Healthcare stocks news, Stocks on the move,